UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 174 filers reported holding UNIQURE NV in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $797,893 | +95.0% | 118,911 | +485.2% | 0.00% | 0.0% |
Q1 2023 | $409,245 | -62.9% | 20,320 | -58.3% | 0.00% | -66.7% |
Q4 2022 | $1,103,530 | +386.1% | 48,678 | +345.2% | 0.01% | +200.0% |
Q4 2021 | $227,000 | -70.2% | 10,934 | -35.5% | 0.00% | -81.8% |
Q2 2020 | $763,000 | – | 16,944 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |